Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M2,421Revenue $M860Net Margin (%)4.5Altman Z-Score3.0
Enterprise Value $M2,506EPS $0.5Operating Margin %8.1Piotroski F-Score4
P/E(ttm)62.9Beneish M-Score-1.6Pre-tax Margin (%)6.9Higher ROA y-yN
Price/Book2.310-y EBITDA Growth Rate %--Quick Ratio2.1Cash flow > EarningsY
Price/Sales2.85-y EBITDA Growth Rate %-13.4Current Ratio2.5Lower Leverage y-yN
Price/Free Cash Flow62.3y-y EBITDA Growth Rate %21.7ROA % (ttm)2.2Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)4.0Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M72.6ROIC % (ttm)4.5Gross Margin Increase y-yN

Gurus Latest Trades with IPXL

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
IPXLNWQ Managers 2015-12-31 Reduce-0.21%$34.53 - $44.76
($40.13)
$ 33.35-17%Reduce -66.75%198,378
IPXLJoel Greenblatt 2015-12-31 Buy 0.01%$34.53 - $44.76
($40.13)
$ 33.35-17%New holding19,801
IPXLNWQ Managers 2015-09-30 Reduce-0.07%$33.27 - $50.42
($45.1)
$ 33.35-26%Reduce -16.00%596,619
IPXLNWQ Managers 2015-06-30 Reduce-0.13%$44.44 - $51.31
($47.45)
$ 33.35-30%Reduce -24.12%710,302
IPXLGeorge Soros 2015-06-30 Sold Out -0.03%$44.44 - $51.31
($47.45)
$ 33.35-30%Sold Out0
IPXLGeorge Soros 2015-03-31 Buy 0.03%$30.2 - $47.3
($39.79)
$ 33.35-16%New holding61,206
IPXLNWQ Managers 2015-03-31 Add0.02%$30.2 - $47.3
($39.79)
$ 33.35-16%Add 3.32%936,127
IPXLJoel Greenblatt 2015-03-31 Sold Out -0.02%$30.2 - $47.3
($39.79)
$ 33.35-16%Sold Out0
IPXLMario Gabelli 2015-03-31 Sold Out -0.0011%$30.2 - $47.3
($39.79)
$ 33.35-16%Sold Out0
IPXLNWQ Managers 2014-12-31 Reduce-0.1%$23.63 - $32.75
($29.3)
$ 33.3514%Reduce -30.25%906,043
IPXLJoel Greenblatt 2014-12-31 Add0.01%$23.63 - $32.75
($29.4)
$ 33.3513%Add 136.17%79,609
IPXLMario Gabelli 2014-12-31 Buy $23.63 - $32.75
($29.3)
$ 33.3514%New holding6,775
IPXLNWQ Managers 2014-09-30 Add0.08%$22.77 - $30.68
($25.55)
$ 33.3531%Add 31.90%1,298,995
IPXLJoel Greenblatt 2014-09-30 Buy 0.01%$22.77 - $30.68
($25.55)
$ 33.3531%New holding33,709
IPXLNWQ Managers 2014-06-30 Buy 0.3%$23.6 - $30.68
($26.93)
$ 33.3524%New holding984,841
IPXLJoel Greenblatt 2012-03-31 Sold Out -0.05%$18.64 - $24.37
($20.72)
$ 33.3561%Sold Out0
IPXLJoel Greenblatt 2011-12-31 Reduce-0.47%$16.53 - $20.75
($18.65)
$ 33.3579%Reduce -88.51%21,057
IPXLJoel Greenblatt 2011-09-30 Reduce-0.38%$15.26 - $21.56
($19.54)
$ 33.3571%Reduce -40.22%183,187
IPXLJoel Greenblatt 2011-06-30 Add0.76%$20.21 - $28.73
($25.28)
$ 33.3532%Add 446.09%306,452
IPXLGeorge Soros 2011-06-30 Sold Out $20.21 - $28.73
($25.28)
$ 33.3532%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

IPXL is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


IPXL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
SCHLOSSBERG MARK ASVP and General Counsel 2015-09-11Sell7,457$43.3-22.98view
NESTOR MICHAELPresident, Impax Pharm. 2015-09-10Sell5,000$43.56-23.44view
FLEMING NIGELDirector 2015-08-31Sell29,166$41.02-18.7view
MARKBREITER MICHAELDirector 2015-08-31Sell28,000$41.7-20.02view
BENET LESLIE ZDirector 2015-08-31Sell20,000$40.92-18.5view
SCHLOSSBERG MARK ASVP and General Counsel 2015-08-27Sell4,649$43.41-23.17view
TERRERI PETER RDirector 2015-08-27Sell4,833$43.93-24.08view
MARKBREITER MICHAELDirector 2015-08-26Sell19,399$42.24-21.05view
HSU LARRYDirector 2014-06-06Sell100,000$28.3817.51view
TERRERI PETER RDirector 2014-05-27Sell3,000$2819.11view

Quarterly/Annual Reports about IPXL:

News about IPXL:

Articles On GuruFocus.com
Kyle Bass Sells Stakes in 11 Health Care Companies Mar 01 2016 
Alan Fournier Makes Modest Reductions in Middleby and Priceline Jan 12 2016 
Allergan Among Health Care Holdings in Alan Fournier's Portfolio Dec 15 2015 
Pharmaceutical Stocks Hold Prominent Positions in Kyle Bass' 3rd-Quarter Activity Nov 27 2015 
Kyle Bass Goes Fishing for These 3 New Holdings Nov 26 2015 
Alan Fournier's Highest Performing Stocks Jul 15 2015 
Alan Fournier's Most Heavily Weighted Trades In Q1 2015 May 28 2015 
Impax Laboratories Inc. Steps Into Profitable Zone Feb 26 2015 
President and CEO of Impax Laboratories Inc. (IPXL) Larry Hsu Bought 10,000 Shares Aug 17 2011 
Impax Laboratories Inc. (IPXL) CEO Larry Hsu buys 5,000 Shares Aug 12 2010 

More From Other Websites
Impax to Report First Quarter 2016 Results on May 10, 2016 Apr 18 2016
Impax to Report First Quarter 2016 Results on May 10, 2016 Apr 18 2016
Impax Announces the Retirement of Nigel Ten Fleming, Ph.D. and Michael Markbreiter from its Board of... Apr 14 2016
Impax Announces the Retirement of Nigel Ten Fleming, Ph.D. and Michael Markbreiter from its Board of... Apr 14 2016
Impax Announces Availability of EMVERM™ (mebendazole) Chewable Tablets, 100 mg Apr 13 2016
Impax Announces Availability of EMVERM™ (mebendazole) Chewable Tablets, 100 mg Apr 13 2016
4 More Good 'Chicken Shorts' Apr 08 2016
Impax Laboratories, Inc. breached its 50 day moving average in a Bullish Manner : IPXL-US : April 7,... Apr 07 2016
[$$] FTC Sues Endo, Alleges Company Paid Off Generic Drugmakers Mar 31 2016
[$$] FTC Accuses Endo of Paying Off Generic Drugmakers Mar 31 2016
FTC accuses Endo, other drugmakers of antitrust violations Mar 31 2016
FTC accuses Endo, other drugmakers of antitrust violations Mar 31 2016
FTC files 'pay-for-delay' complaint against drug maker Endo Mar 31 2016
Allergan Broke Antitrust Laws With Endo Drug Deal, U.S. Says Mar 31 2016
U.S. FTC sues Endo for violating antitrust laws Mar 31 2016
Impax Laboratories, Inc. – Value Analysis (NASDAQ:IPXL) : March 15, 2016 Mar 15 2016
Impax Laboratories, Inc. breached its 50 day moving average in a Bullish Manner : IPXL-US : March... Mar 14 2016
Small-Caps: Hedge Fund Favorites Mar 11 2016
Impax to Present at the Barclays Global Healthcare Conference Mar 11 2016
IMPAX LABORATORIES INC Files SEC form 8-K, Costs Associated with Exit or Disposal Activities, Other... Mar 09 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)